Adaptimmune Acquisitions
Adaptimmune has acquired 1 company and its latest acquisition was TCR2 Therapeutics, Inc. on Mar 2023
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
TCR2 Therapeutics, Inc.
Mar 2023
Source »undisclosed
TCR2 is a Massachusetts-based biotechnology company that researches and develops T-cell receptor therapies for the treatment of hematological malignancies and solid tumors.